TAxI holds promise as a carrier for spinal cord treatments
17 February 2016 | By Victoria White
The small peptide has been shown to be an effective at shuttling functional proteins into the spinal cord after a muscle injection...
List view / Grid view
17 February 2016 | By Victoria White
The small peptide has been shown to be an effective at shuttling functional proteins into the spinal cord after a muscle injection...
3 September 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that Alexander Gaidamaka has been appointed as the new Vice President of Chemistry, Manufacturing and Control...
14 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Biotechnology company, AmpliPhi Biosciences Corporation, released financial results for the second quarter 2015 and operational highlights. AmpliPhi, one of the leaders in the development of bacteriophage-based antibacterial therapies to treat antibiotic-resistant infections, has reported strong overall performance in overall liquidity and balance sheet strength thanks to a $13 million investment…
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
16 April 2015 | By Victoria White
Ferring and Institut Pasteur are collaborating aimed at identifying and developing bacteriophages to treat patients with inflammatory bowel disease (IDB)...